Measures of lung capacity over the long term (greater than 1 year) · children and young males with DMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Measures of lung capacity over the long term (greater than 1 year) · children and young males with DMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Measures of lung capacity over the long term (greater than 1 year) · participants with limb‐girdle muscular dystrophy or Becker muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Measures of lung capacity over the long term (greater than 1 year) · people with ALS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Measures of lung capacity over the long term (greater than 1 year) · people with myasthenia gravis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality within the longest · adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older…
Omega‐3 fatty acids and antioxidants showed no clear difference in all‐cause mortality (longest period reported) compared with placebo or standard nutrition (low certainty).
1 finding from 1 review
Mental state: psychotic symptoms Average total score (PANSS, higher score = worse, scale from 30‐210) Long‐term (up to 7 years) · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · people in the prodromal stage of psychosis
Group A: omega‐3 fatty acids showed no clear difference in satisfaction with treatment: leaving the study early Long‐term… compared with placebo (low certainty).
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes prodromal symptoms: transition to psychosis Long‐term (events) compared with supportive therapy (very low certainty).
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · people in the prodromal stage of psychosis
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes prodromal symptoms: transition to psychosis Endpoint data (events)… compared with needs‐based intervention (very low certainty).
1 finding from 1 review
QoL · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early (events)… compared with needs‐based intervention (very low certainty).
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · people in the prodromal stage of psychosis
It is very uncertain whether group C other: cognitive training changes satisfaction with treatment: leaving the study early Endpoint data… compared with active control (tablet games) (very low certainty).
1 finding from 1 review
Prodromal symptoms: transition to psychosis FACT Long‐term · people in the prodromal stage of psychosis
It is very uncertain whether group C other: family treatment changes prodromal symptoms: transition to psychosis FACT Long‐term compared with enhanced care (very low certainty).
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
Group A: omega‐3 fatty acids may leads to lower prodromal symptoms: transition to psychosis Long‐term (events) compared with placebo (low certainty).
1 finding from 1 review
Suicide · people in the prodromal stage of psychosis
It is very uncertain whether group C other: family treatment changes adverse events: suicide (events) Long‐term (by 24 months) compared with enhanced care (very low certainty).
1 finding from 1 review
Satisfaction with treatment: leaving the study early FACT Long‐term · people in the prodromal stage of psychosis
It is very uncertain whether group C other: family treatment changes satisfaction with treatment: leaving the study early FACT Long‐term compared with enhanced care (very low certainty).
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group C other: integrated treatment changes prodromal symptoms: transition to psychosis Endpoint data (events)… compared with standard treatment (very low certainty).
1 finding from 1 review
Global state: antipsychotic prescription Long‐term (events) · people in the prodromal stage of psychosis
Group A: omega‐3 fatty acids may leads to lower global state: antipsychotic prescription Long‐term (events) compared with placebo (low certainty).
1 finding from 1 review